I'd focus particularly on the elimination of capital expenditures from the SR and ED. I know the logic behind it, at least in the Jenkins report, was to make it easier to file and to remove some of the complication from it. But I can tell you for many of our companies if they're going to make R and D investments the issue is not necessarily whether or not they would make the investments; it's whether they would make the investments in Canada.
On October 7th, 2014. See this statement in context.